| Assessment of variability in the plasma 7k SomaScan proteomics assay J Candia, GN Daya, T Tanaka, L Ferrucci, KA Walker Scientific reports 12 (1), 17147, 2022 | 109 | 2022 |
| Plasma proteins related to inflammatory diet predict future cognitive impairment MR Duggan, L Butler, Z Peng, GN Daya, A Moghekar, Y An, SR Rapp, ... Molecular psychiatry 28 (4), 1599-1609, 2023 | 21 | 2023 |
| Persistent psychosis due to single dose of ecstasy S Virani, GN Daya, N Brainch, VP Kotapati, D Zaveri, S Ahmed Cureus 10 (7), 2018 | 13 | 2018 |
| Association of liver disease with brain volume loss, cognitive decline, and plasma neurodegenerative disease biomarkers Z Peng, MR Duggan, HE Dark, GN Daya, Y An, C Davatzikos, G Erus, ... Neurobiology of aging 120, 34-42, 2022 | 12 | 2022 |
| Proteomic Indicators of Health Predict Alzheimer's Disease Biomarker Levels and Dementia Risk HE Dark, C Paterson, GN Daya, Z Peng, MR Duggan, M Bilgel, Y An, ... Annals of neurology 95 (2), 260-273, 2024 | 9 | 2024 |
| Proteomics identifies potential immunological drivers of postinfection brain atrophy and cognitive decline MR Duggan, Z Peng, PN Sipilä, JV Lindbohm, J Chen, Y Lu, C Davatzikos, ... Nature Aging 4 (9), 1263-1278, 2024 | 3 | 2024 |
| A plasma proteomic signature links secretome of senescent monocytes to aging-and obesity-related clinical outcomes in humans N Basisty, B Olinger, R Banarjee, A Dey, D Tsitsipatis, T Tanaka, A Ram, ... | | 2024 |
| A plasma proteomic signature links secretome of senescent monocytes to aging-and obesity-related clinical outcomes in humans B Olinger, R Banarjee, A Dey, D Tsitsipatis, T Tanaka, A Ram, T Nyunt, ... medRxiv, 2024 | | 2024 |
| SomaScan plasma proteomics of cSVD GT Gomez, L Shi, AE Fohner, J Chen, Y Yang, M Fornage, MR Duggan, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Plasma proteome-wide analysis of cerebral small vessel disease identifies novel biomarkers and disease pathways GT Gomez, L Shi, AE Fohner, J Chen, Y Yang, M Fornage, MR Duggan, ... medRxiv, 2024.10. 07.24314972, 2024 | | 2024 |
| Proteomics identifies immunological drivers of post‐infection brain atrophy and cognitive decline MR Duggan, Z Peng, P Sipilä, JV Lindbohm, M Kivimaki, C Davatzikos, ... Alzheimer's & Dementia 19, e071642, 2023 | | 2023 |
| Association of protein-based indices with brain volume and cognition in the Baltimore Longitudinal Study of Aging (BLSA)(P12-6.007) G Daya, H Dark, M Duggan, Z Peng, AZ Moore, T Tanaka, J Candia, ... Neurology 100 (17_supplement_2), 2448, 2023 | | 2023 |
| Plasma proteins related to inflammatory diet predict future cognitive impairment (Feb, 10.1038/s41380-023-01975-7, 2023) MR Duggan, L Butler, Z Peng, GN Daya, A Moghekar, Y An, SR Rapp, ... MOLECULAR PSYCHIATRY 28 (4), 1610-1610, 2023 | | 2023 |
| Proteomic indicators of health relate to Alzheimer’s and neurodegenerative disease biomarkers HE Dark, Z Peng, MR Duggan, G Daya, M Bilgel, Y An, A Moghekar, ... Alzheimer's & Dementia 18, e069074, 2022 | | 2022 |
| Proteomic Indicators of Cardiovascular Health Relate to Brain Volume and Dementia Risk HE Dark, C Paterson, Z Peng, MR Duggan, GN Daya, M Bilgel, Y An, ... Circulation 146 (Suppl_1), A13280-A13280, 2022 | | 2022 |
| Persistent Psychosis due to Single Dose of Ecstasy V Sanya, GN Daya, B Navjot, KV Padma, Z Deval, S Ahmed Cureus 10 (7), 2018 | | 2018 |
| Association of Liver Disease with Brain Volume Loss, Cognitive Decline, and Neurodegenerative Disease Biomarkers Z Peng, MR Duggan, HE Dark, GN Daya, Y An, C Davatzikos, G Erus, ... Cognitive Decline, and Neurodegenerative Disease Biomarkers, 0 | | |
